First Assist: The Historical Context of NMIBC, with Kamal Pohar, MD
非muscle浸透性膀胱癌(NMIBC)的历史背景和管理策略。NMIBC的管理和 surveillance strategy已经发生了很大的变化。BCG是最早被用于治疗NMIBC的药物,它的dosage和维持方案也已经被确定。 Surveillance strategies, repeat transurethral resection of the bladder tumor for T1 tumors, and the introduction of enhanced cystoscopy techniques like blue light and narrow band imaging have proven impact on tumor detection and recurrence。Biomarkers like traditional cytology, UroVysion FISH and risk stratification models (EORTC, CUETO) are also important tools for NMIBC management。Perioperative intravesical chemotherapy, the impact of BCG shortages, and exciting frontiers like recombinant BCG and en bloc resection techniques will continue to shape the rapidly evolving field of NMIBC management。
来源: urologytimes
原文链接:原文
麦圈 Medprober 编辑部 · 审校:泌尿外科临床医生团队
免责声明:本文为医学信息整理与解读,仅供参考,不能替代医师面诊与诊疗意见。具体诊疗请遵从面诊医生。
本文由作者按照 CC BY 4.0 进行授权